Visceral leishmaniasis and other severe infections in an adult patient with p47-phox-deficient chronic granulomatous disease

Infection

Volumn 28, Issue 3, 2000, Pages 171-174

  Asensi, V ^a   Tricas, L ^a   Meana, A ^a   Roos, D ^b   Carton, J A ^a   Maradona, J A ^a   Fresno, M F ^a   Valle, E ^a   Fierer, J ^c   Arribas, J M ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Netherlands Red Cross Transfus S   (Netherlands)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adult chronic granulomatous disease; Brain abscess; Leishmania; p47 phox mutation; Pneumonia

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; DNA; ERYTHROMYCIN; GAMMA INTERFERON; ITRACONAZOLE; MEGLUMINE ANTIMONATE; METRONIDAZOLE; NITROBLUE TETRAZOLIUM; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL INFECTION; BRAIN ABSCESS; CASE REPORT; CHRONIC GRANULOMATOUS DISEASE; DNA DETERMINATION; FOLLOW UP; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MYCOSIS; PNEUMONIA; PROTEIN DEFICIENCY; VISCERAL LEISHMANIASIS;

ADULT; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBODIES, PROTOZOAN; BONE MARROW; FOLLOW-UP STUDIES; GRANULOMATOUS DISEASE, CHRONIC; HOMOZYGOTE; HUMANS; INTERFERON TYPE II; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LEUKOCYTES; MALE; NADPH OXIDASE; PHOSPHOPROTEINS; SPAIN; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0034033739     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s150100050074     Document Type: Article

References (19)

1. 1. Gallin JI, Buescher ES, Seligmann BE, Nath J, Gaither T, Katz P: Recent advances in chronic granulomatous disease. Ann Intern Med 1983;99:657-674.
2. 2. Roos D, Curnutte JT: Chronic granulomatous disease. In: Ochs HD, Smith E, Puck J (eds): Primary immunodeficiency diseases: a molecular and genetic approach. Oxford University Press, New York 1999, pp 353-373.
3. 3. Ochs HD, Igo RP: The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers. J Pediatr 1973;83:77-82.
4. 4. Roesler J, Hecht M, Freihost J, Lohmann-Matthes ML, Emmendorffer E: Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorimetry. Eur J Pediatr 1991;150:160-165.
5. 558 of human neutrophils. Blood 1989;73:1686-1694.
6. 6. Roos D, de Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, Ahlin A, Nemet K, Hossle JP, Bernatowska-Matuskiewicz E, Middleton-Price H: Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996;87: 1663-1681.
7. 7. Fernández-Guerrero ML, Aguado JM, Buzón L, Barros C, Montalban C, Martin T, Bouza E: Visceral leishmaniasis in immunocompromised hosts. Am J Med 1987;83:1098-1102.
8. 8. Montalbán C, Martinez-Fernández R, Calleja JL, Garcia-Diaz JD, Rubio R, Dronda F, Moreno S, Yebra M, Barros C, Cobo J, Martinez MC, Ruiz F, Costa JR: Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain. Rev Infect Dis 1989;11:655-660.
9. 9. Murray HW, Cartelli DM: Killing of intracellular Leishmania donovani by human mononuclear phagocytes: evidence for oxygen-dependent and -independent leishmanicidal activity. J Clin Invest 1983;72:32-44.
10. 10. The International Chronic Granulomatous Disease Cooperative Study Group: A phase III study establishing efficacy of recombinant human interferon gamma for infection prophylaxis in chronic granulomatous disease. N Engl J Med 1991;324: 509-516.
11. 11. Gallin JI, Farber JM, Holland SM, Nutman TB: Interferon-γ in the management of infectious diseases. Ann Intern Med 1995;123: 216-224.
12. 12. Murray HW, Rubin BY, Rothermel CD: Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes: evidence of that interferon-γ is the activating lymphokine. J Clin Invest 1983;72:1506-1510.
13. 13. Badaró R, Falcoff E, Badaró FS, Carvalho EM, Pedral-Sampaio D, Barral A, Carvalho JS, Barral-Netto M, Brandely M, Silva L, Bina JC, Teixeira R, Falcoff R, Rocha H, Ho JL, Johnson WD: Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med 1990;322:16-21.
14. 14. Kowanko IC, Ferrante A, Clement G, Kumaratilake LM: Tumor necrosis factor primes neutrophils to kill Staphylococcus aureus by an oxygen-dependent mechanism and Plasmodium falciparum by an oxygen-independent mechanism. J Immunol 1996; 64:3435-3437.
15. 15. Weening RS, Kabel P, Pijman P, Roos D: Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr 1983;103:127-130.
16. 16. Margolis DM, Melnick DA, Alling DW, Gallin JI: Trimethoprimsulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 1990;162:723-726.
17. 17. Mouy R, Verber F, Blanche S, Donadieu J, Brauner R, Levron JC, Griscelli C, Fischer A: Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with granulomatous disease. J Pediatr 1994;125:998-1003.
18. 18. Liese JG, Jendrossek V, Jansson A, Petropoulou T, Kloos S, Gahr M, Belohradsky BH: Chronic granulomatous disease in adults. Lancet 1996;347:220-223.
19. 19. Malech HL: Progress in gene therapy for chronic granulomatous disease. J Infect Dis 1999;179(suppl 2):S318-S325.